4//SEC Filing
Mullennix Stephen 4
Accession 0001209191-20-006211
CIK 0001668243other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 12:39 PM ET
Size
8.1 KB
Accession
0001209191-20-006211
Insider Transaction Report
Form 4
Mullennix Stephen
Chief Operating Officer
Transactions
- Award
Stock options (right to buy)
2020-01-31+15,000→ 15,000 totalExercise: $29.41→ Ordinary Shares (15,000 underlying) - Award
Restricted stock unit
2020-01-31+3,000→ 3,000 total→ Ordinary Shares (3,000 underlying)
Footnotes (3)
- [F1]1/3rd of the shares underlying the stock option vest on January 31, 2021 and 1/12th of the shares underlying the stock option vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F3]1/3rd of the shares underlying the RSU vest on January 31, 2021 and 1/12th of the shares underlying the RSU vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001764139
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 12:39 PM ET
- Size
- 8.1 KB